export const userData = {
  name: "N. D. Prasad Atmuri, Ph.D.",
  title: "Associate Principal Scientist",
  company: "NanoVation Therapeutics Inc.",
  location: "Vancouver, BC, Canada",
  email: "ndprasad.atmuri@gmail.com",
  phone: "+1-2363309977",
  profileImage: "/api/placeholder/400/400",
  impactScore: 782,
  summary:
    "Over seventeen years of experience working in synthetic chemistry labs as a medicinal chemist and team leader, with extensive understanding and knowledge in the synthesis of a broad spectrum of lipid architectures, nucleotides (mRNA caps), and small molecules to enable a wide variety of therapeutic applications.",
  achievements: {
    publications: 8,
    patents: 3,
    presentations: 3,
    citations: 117,
    collaborators: 24,
    contributions: 46,
  },
  badges: [
    { name: "Top Contributor", icon: "Trophy" },
    { name: "Verified Researcher", icon: "FileCheck" },
    { name: "Thought Leader", icon: "Target" },
  ],
  skills: [
    { name: "Synthetic Chemistry", level: 95 },
    { name: "Medicinal Chemistry", level: 90 },
    { name: "Nucleotides & mRNA Design", level: 85 },
    { name: "Lipid Nanoparticles", level: 88 },
    { name: "Laboratory Instrumentation", level: 80 },
    { name: "Chemical Analysis", level: 85 },
  ],
  experience: [
    {
      role: "Associate Principal Scientist",
      company: "NanoVation Therapeutics Inc.",
      location: "Vancouver, BC",
      duration: "10/2022 – Current",
      description:
        "Design and synthesis of various novel lipids and mRNA caps. Understanding the function of lipids in the composition of lipid nanoparticles (LNP) with the aim of developing safe, stable, and effective delivery systems to the target cells and tissues.",
    },
    {
      role: "Senior Synthetic Chemist",
      company: "NanoVation Therapeutics Inc.",
      location: "Vancouver, BC",
      duration: "10/2021 – 09/2022",
      description:
        "Designing novel lipids from prior art searches, synthesis, and characterization, with an emphasis on tailored LNP designs and enhancing the organization's intellectual property portfolio.",
    },
    {
      role: "Mitacs Accelerate Postdoctoral Fellow",
      company: "University of British Columbia",
      location: "BC",
      duration: "08/2019 – 09/2021",
      description:
        "Design and Synthesis of cathepsin k protein inhibitors (Azatanshinone analogs), Angiotensin receptor blockers - and Angiotensin-converting enzyme (ACE) inhibitors-like small molecules.",
    },
  ],
  education: [
    {
      degree: "Ph.D. in Organic and Medicinal Chemistry",
      institution: "Université de Montréal",
      location: "Montréal, QC, Canada",
      duration: "01/2015 – 03/2019",
      thesis:
        "Design, synthesis and biological applications of azabicycloalkanone amino acid peptidomimetics",
    },
    {
      degree: "M.Sc. in Organic Chemistry",
      institution: "Université de Montréal",
      location: "Montréal, QC, Canada",
      duration: "01/2013 – 12/2014",
      thesis: "Azabicycloalkanone synthesis by Transannular Cyclization",
    },
    {
      degree: "M.Sc. in Organic Chemistry",
      institution: "Nagarjuna University",
      location: "India",
      duration: "05/2004 – 04/2006",
    },
  ],
  certifications: [
    {
      name: "Introduction to Molecular Modeling in Drug Discovery",
      issuer: "Schrödinger, Inc.",
      year: "2022",
    },
    {
      name: "High-Throughput Virtual Screening for Hit Finding and Evaluation",
      issuer: "Schrödinger, Inc.",
      year: "2022",
    },
    {
      name: "Business Analysis Fundamentals",
      issuer: "Sauder school of business, UBC",
      year: "2023",
    },
  ],
  patents: [
    {
      title: "Sulfur-containing lipids",
      number: "WO2023215989A1 WIPO (PCT)",
      date: "Nov 16, 2023",
      link: "#",
    },
    {
      title: "Synthetic method for producing ionizable amino lipids",
      number: "WO2023173203A1 WIPO (PCT)",
      date: "Sep 21, 2023",
      link: "#",
    },
    {
      title:
        "Method for producing ionizable lipids or intermediates for the synthesis of such lipids",
      number: "WO2023147657A1 WIPO (PCT)",
      date: "Aug 10, 2023",
      link: "#",
    },
  ],
  publications: [
    {
      title:
        "Losartan metabolite EXP3179 is a unique blood pressure-lowering AT1R antagonist with direct, rapid endothelium-dependent vasoactive properties",
      journal: "Vasc. Pharmacol.",
      year: "2022",
      volume: "147",
      pages: "107112",
      citations: 8,
      link: "#",
    },
    {
      title:
        "Stereo- and regiochemical transannular cyclization of a common hexahydro-1H-azonine to afford three different indolizidinone dipeptide mimetics",
      journal: "J. Org. Chem.",
      year: "2020",
      volume: "85",
      pages: "1340–1351",
      citations: 14,
      link: "#",
      highlight: "Selected as cover page",
    },
    {
      title:
        "Paired Utility of Aza-Amino Acyl Proline and Indolizidinone Amino Acid Residues for Peptide Mimicry",
      journal: "J. Med. Chem.",
      year: "2019",
      volume: "62",
      pages: "4500–4525",
      citations: 27,
      link: "#",
      highlight: "Equal Contribution",
    },
  ],
  presentations: [
    {
      title:
        "Peptidomimetic Synthesis by Transannular Cyclization and Iodoacetoxylation",
      event:
        "28th Québec-Ontario Mini-Symposium for Synthetic and Bioorganic Chemistry",
      location: "McGill, Montreal",
      date: "November 11, 2017",
      type: "Oral",
    },
    {
      title:
        "A general synthetic strategy for making azabicyclo[X.Y.0]alkanone peptidomimetics",
      event:
        "The 19th Concordia Chemistry and Biochemistry Graduate Research Conference",
      location: "Concordia University, Montreal",
      date: "November 18, 2016",
      type: "Poster",
    },
  ],
  awards: [
    {
      title: "Stronger BC future skills grant",
      issuer: "Continuing Business Studies, Sauder School of Business",
      year: "2023",
      detail: "Worth 3500 CAD",
    },
    {
      title: "Mitacs accelerate post-doctoral fellowship",
      issuer: "Mitacs",
      year: "2020-2021",
    },
    {
      title: "Bourse de fin d'études doctorales",
      issuer: "Université de Montréal",
      year: "2018",
      detail: "Worth 10,000 CAD",
    },
  ],
  recentActivity: [
    {
      type: "publication",
      title: "Commented on 'Recent Advances in mRNA Delivery Systems'",
      date: "2 days ago",
    },
    {
      type: "webinar",
      title: "Attended webinar on 'Next Generation Lipid Nanoparticles'",
      date: "1 week ago",
    },
    {
      type: "forum",
      title: "Answered question on 'Optimization of Ionizable Lipid Synthesis'",
      date: "2 weeks ago",
    },
    {
      type: "certification",
      title: "Completed 'Advanced Molecular Design' certification",
      date: "1 month ago",
    },
  ],
};

export const impactBreakdown = [
  { category: "Publications & Patents", score: 312, color: "bg-blue-600" },
  { category: "Research Contributions", score: 215, color: "bg-purple-600" },
  { category: "Community Engagement", score: 176, color: "bg-green-600" },
  { category: "Platform Activity", score: 79, color: "bg-amber-500" },
];
export const relatedResearchers = [
  {
    id: 1,
    name: "Dr. William D. Lubell",
    avatar: "/api/placeholder/100/100",
    title: "Professor of Chemistry",
    match: 92,
  },
  {
    id: 2,
    name: "Dr. Marco A. Ciufolini",
    avatar: "/api/placeholder/100/100",
    title: "Research Director",
    match: 88,
  },
  {
    id: 3,
    name: "Dr. Fatemeh Saadati",
    avatar: "/api/placeholder/100/100",
    title: "Senior Scientist",
    match: 85,
  },
];

export const fadeInUpVariants = {
  hidden: { opacity: 0, y: 20 },
  visible: {
    opacity: 1,
    y: 0,
    transition: {
      duration: 0.6,
      ease: "easeOut",
    },
  },
};
export const fadeInVariants = {
  hidden: { opacity: 0 },
  visible: {
    opacity: 1,
    transition: { duration: 0.5 },
  },
};
export const staggerContainerVariants = {
  hidden: { opacity: 0 },
  visible: {
    opacity: 1,
    transition: {
      staggerChildren: 0.1,
    },
  },
};
